Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RTP-026 in STEMI Patients
NCT06465303Phase 2Completed
- Sponsor
- ResoTher Pharma
- Start
- Jul 2024
- Primary completion
- Jul 2026
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of RTP-026 in ST elevation myocardial infarction (STEMI), sponsored by ResoTher Pharma. Started Jul 2024; status: completed.
02
Drugs
RTP-026
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT06465303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06465303.